PRTN3 and rheumatoid arthritis: Elevation of Th17.1 cells levels have been observed in anti-citrullinated protein antibodies (ACPA) positive RA patients with worse disease outcome, than in ACPA negative RA patients (Paulissen et al., 2015b).